Quantum-Si (NASDAQ:QSI) CEO Sells $10,857.60 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) CEO Jeffrey Alan Hawkins sold 11,310 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $0.96, for a total value of $10,857.60. Following the transaction, the chief executive officer directly owned 3,681,113 shares of the company’s stock, valued at $3,533,868.48. The trade was a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Jeffrey Alan Hawkins also recently made the following trade(s):

• On Tuesday, June 23rd, Jeffrey Alan Hawkins sold 11,311 shares of Quantum-Si stock. The stock was sold at an average price of $0.90, for a total value of $10,179.90.
• On Monday, April 20th, Jeffrey Alan Hawkins sold 83,712 shares of Quantum-Si stock. The shares were sold at an average price of $1.01, for a total value of $84,549.12.

Quantum-Si Price Performance

QSI stock opened at $0.85 on Friday. The business’s 50-day moving average is $0.99 and its two-hundred day moving average is $1.03. The firm has a market capitalization of $186.14 million, a P/E ratio of -1.68 and a beta of 3.18. Quantum-Si Incorporated has a 1 year low of $0.69 and a 1 year high of $3.10.

Quantum-Si (NASDAQ:QSI) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.10) EPS for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%.The business had revenue of $0.26 million during the quarter, compared to the consensus estimate of $0.30 million. On average, analysts expect that Quantum-Si Incorporated will post -0.49 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in QSI. Invesco Ltd. boosted its holdings in shares of Quantum-Si by 177.7% in the first quarter. Invesco Ltd. now owns 103,657 shares of the company’s stock valued at $124,000 after acquiring an additional 66,336 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Quantum-Si by 23.8% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 70,552 shares of the company’s stock valued at $85,000 after acquiring an additional 13,546 shares during the period. Millennium Management LLC acquired a new position in shares of Quantum-Si in the 1st quarter valued at $4,721,000. JPMorgan Chase & Co. increased its holdings in shares of Quantum-Si by 15.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 66,656 shares of the company’s stock valued at $131,000 after acquiring an additional 9,005 shares during the period. Finally, Rhumbline Advisers raised its position in Quantum-Si by 36.0% in the 2nd quarter. Rhumbline Advisers now owns 203,967 shares of the company’s stock valued at $400,000 after purchasing an additional 53,994 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on QSI shares. Weiss Ratings reiterated a “sell (d-)” rating on shares of Quantum-Si in a report on Wednesday. Canaccord Genuity Group decreased their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 4th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Quantum-Si has an average rating of “Reduce” and a consensus price target of $1.00.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.